Blood Plasma Market

Global Blood Plasma Market: Overview

Blood plasma refers to the liquid part of the blood. It is a versatile element and it comprises around 55% of the blood. This component is basically a composite mixture of over 700 proteins and many other substances that are essential for the effective working of human body. Blood plasma assists in the regulation of blood pressure and body temperature. Working as a platform for exchange of hormones, nutrients, and proteins to various parts of the human body, blood plasma has gained increased importance. Riding on the back of these factors, the global blood plasma market is likely to observe substantial growth over the period of forecast, from 2020 to 2030.

Some of the main proteins found in plasma comprise immunoglobulin, albumin, and clotting factor. Plasma is derived in the form of substances and proteins and are widely utilized as a major component in various medical products so as to make a replacement of antibodies, clotting factors, and body fluids. Plasma is widely utilized as an element in the treatment of various grave health issues, such autoimmune disorders and hemophilia. Growing importance of plasma is expected to fuel growth of the global blood plasma market in the years to come.

The global blood plasma market has been classified based on four significant parameters, which are components, application, end user, and region. Such segmentation offers better insight into the market.

Global Blood Plasma Market: Notable Developments

The global blood plasma market has experienced some path-breaking, important developments over the last few years. The market is considered fragmented one with the presence of a number of prominent pharma manufacturers across the globe. Most of the leading players in the global blood plasma market are relying on relentless research and development activities to come up with better, improved product in the market. Strategic mergers and acquisitions are also expected to play important role in shaping the future course of the market.

Some of the prominent companies in the global blood plasma market are mentioned below:

• Kedrion S.p.A.
• Octopharma AG
• Grifols S.A.
• Baxter International Inc.
• Sanquin
• Grifols, S.A.

Global Blood Plasma Market: Key Trends

The global blood plasma market is characterized by the prevalence of the following challenges, market drivers, and promising opportunities.

Increased Prevalence of Cases of Hemophilia to Support Growth of the Market

Temperature of the body and blood pressure is regulated by plasma. It serves the role of a medium for hormone, protein, and nutrient exchange within the various parts of the body. The global blood plasma market is expected to observe considerable growth due to the presence of several growth factors. Increasing demand for blood plasma in the last few years due to increasing prevalence of hemophilia amongst people across the globe is likely to augur well for the market over the timeframe of analysis, from 2020 to 2030.

In addition to that, changing and hectic lifestyle of people has resulted in the emergence of several health-related issues. With the rising health issues, the demand for blood plasma is expected to rise. Furthermore, increasing penetration of plasma-based products together with augmented expenditure pertaining to healthcare is likely to add to the growth of the global blood plasma market over the tenure of projection, from 2020 to 2030.

Global Blood Plasma Market: Geographical Analysis

In the global blood plasma market, North America is likely to steer growth of the market and is estimated to remain one of the dominant regional force in the years to come. Increased spending on the research and development activities that could bring new, innovative developments in the biomedical technology is expected to observe growth of North America market in the years to come.